GERPAC award 2024 for the best oral communication

7 October 2024

Physical stability of bevacizumab solutions for intravitreal injections: influence of the packaging device and storage conditions
J. Claves1, A. Freisz1, V. Sautou2, Ph. Chennell2

1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF,
F-63000 Clermont-Ferrand, France

Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressured intraperitoneal aerosol chemotherapy

G. Galy1, V. D’Atri2, M. Buff2, M. Imiolek3, M Hübner4, S. Intidhar Labidi-Galy5, D. Guillarme2, L. Carrez1
1 Service Pharmacie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Suisse
2 Institut des Sciences Pharmaceutiques de Suisse occidentale, Université de Genève, CMU Genève, Suisse
3 Waters Corporation, Genève, Suisse
4 Service de chirurgie viscérale, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Université de Lausanne (UNIL)
5 Département d’oncologie, Hôpitaux Universitaires de Genève, Genève, Suisse

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data